HOME > 研究業績

研究業績

外科腫瘍学,先端外科学など

[1]欧文によるもの

1 Furukawa, T. Kubota, T., Suto, A., Takahara, T., Yamaguchi, H., Takeuchi, T., Kase, K., Kodaira, S., Ishibiki, K. and Kitajima, M. Clinical usefulness of chemosensitivity testing using the MTT assay. Journal of Surgical Oncology, 48, 188-193, 1991.
2 Furukawa, T., Kubota, T., Watanabe, M., Kase, S., Saikawa, Y., Nishibori, H., Kuo, T., Kodaira, S., Ishibiki, K. and Kitajima, M. Increased drug resistance of cultured human cancer cell lines in three-dimensional cellular growth assay using collagen gel matrix. Journal of Surgical Oncology, 49, 86-92, 1992.
3 Furukawa, T., Kubota, T., Watanabe, M., Takahara, T., Yamaguchi, H., Takeuchi, T., Kase, K., Kodaira, S., Ishibiki, K., Kitajima, M. and Hoffman R.M. High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end-point. International Journal of Cancer, 51, 489-498, 1992.
4 Furukawa, T., Watanabe, M., Kubota, T., Yamaguchi, H., Teramoto, T., Ishibiki, K. and Kitajima, M. Production of human Immunoglobulin G reactive against human cancer in tumor-bearing mice with severe combined immunodeficiency reconstituted with human splenic tissues. Japanese Journal of Cancer Research, 83, 894-898, 1992.
5 Furukawa, T., Kubota, T., Watanabe, M., Kase, S., Takahara, T., Yamaguchi, H., Takeuchi, T., Teramoto, T., Ishibiki, K., Kitajima, M. and Hoffman R.M. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point. Anticancer Research, 12, 1377-1382, 1992.
6 Kubota, T., Yamaguchi, H., Watanabe, M., Yamamoto, T., Takahara, T., Takeuchi,T., Furukawa, T., Kase, S., Kodaira, S., Ishibiki, K. and Kitajima, M. High human IgG levels in severe combined immunodeficient mouse reconstituted with human splenic tissues from patients with gastric cancer. Japanese Journal of Cancer. Research, 83, 300-303, 1992.
7 Kubota, T., Yamamoto, T., Takahara, T., Furukawa, T., Ishibiki, K., Kitajima, M., Shida, Y. and Nakatsubo, H. Targeting cancer chemotherapy using a monoclonal antibody (NCC-LU-243) conjugated with Mitomycin C. Journal of Surgical Oncology, 51, 75-80, 1992.
8 Kubota, T., Kase, S., Furukawa, T., Tanino, H., Kuo, T., Saikawa, Y., Nishibori, H., Ishibiki, K., Kitajima, M., Mabuchi, K. and Hirata, H. Modulation of l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice. Anticancer Research, 12, 1549-1554, 1992.
9 Kuo, T., Kubota, T., Watanabe, M., Furukawa, T., Kase, S., Tanino, H., Nishibori, H., Saikawa, Y., Teramoto, T., Ishibiki, K., Kitajima, M. and Hoffman, R.M. Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice. Anticancer Research, 12, 1407-1410, 1992.
10 Furukawa, T., Kumai, K., Kubota, T., Hirahata, S., Shimizu, H., Matsui, H., Takahara, T., Aizawa, K., Shibata, S., Shimada, A., Yoshino, K. and Ishibiki, K. and Kitajima, M. Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers. Surgery Today, 23, 298-306, 1993.
11 Furukawa, T., Kubota, T., Watanabe, M., Kuo, T., Nishibori, H., Saikawa, Y., Kase, S., Tanino, H., Teramoto, T., Ishibiki, K. and Kitajima, M. A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice. Surgery Today, 23, 420-423, 1993.
12 Furukawa, T., Kubota, T., Watanabe, M., Nishibori, H., Kuo, T., Saikawa, Y., Kase, S., Tanino, H., Teramoto, T., Ishibiki, K. and Kitajima, M. A suitable model of experimental liver metastases of human colon cancer xenografts using mice with severe combined immunodeficiency. Journal of Surgical Oncology, 52, 64-67, 1993.
13 Furukawa, T., Kubota, T., Watanabe, M., Kuo, T., Kase, S., Saikawa, Y., Tanino, H., Teramoto, T., Ishibiki, K., Kitajima, M. and Hoffman, R.M. Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intct tumor tissue in nude mice. Anticancer    Research, 13, 287-292, 1993.
14 Furukawa, T., Kubota, T., Watanabe, M., Kitajim, M. and Hoffman, R.M. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: Correlation of metastatic sites in mouse and individual patient donors. International Journal of Cancer, 53, 608-612, 1993.
15 Furukawa, T., Fu, X., Kubota, T., Watanabe, M., Kitajima, M. and Hoffman, R.M. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Research, 53, 1204-1208, 1993.
16 Furukawa, T., Watanabe, M., Kubota, T., Kase, S., Fujita, S., Yamamoto, T., Saikawa, Y., Kuo, T., Tanino, H., Kurihara, N., Kawano, Y., Kawamoto, K., Suto, A., Teramoto, T., Ishibiki, K. and Kitajima, M. Significance of in vitro attachment of human colon cancers to extracellular matrix proteins in experimental and clinical liver metastases. Journal of Surgical Oncology, 53, 10-16, 1993.
17 Furukawa, T., Kubota, T., Watanabe, M., Kuo, T., Kitajima, M. and Hoffman, R.M. Differential chemosensitivity of local and metastatic human stomach cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice. International Journal of Cancer, 54, 397-401, 1993.
18 Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M. and Hoffman, R.M. A novel “patient-like” treatment model of human pancreatic cancer using orthotopic transplantation of histologically-intact human tumor-tissue in nude mice. Cancer Research, 53, 3070-3072, 1993.
19 Kubota, T., Yamaguchi, H., Watanabe, M., Yamamoto, T., Takahara, T., Takeuchi, T., Furukawa, T., Kase, S., Kodaira, S., Ishibiki, K. and Kitajima, M. Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID). Surgery Today, 23, 375-377, 1993.
20 Kuo, T., Nishibori, H., Watanabe, M., Furukawa, T., Fujita, S., Kase, S., Tanino, H., Saikawa, Y., Teramoto, T., Kubota, T. and Kitajima, M. Experimental cancer chemotherapy using a liver metastatic model of human colon cancer transplanted into the spleen of severe combined immunodeficient mice. Journal of Surgical Oncology, 52, 92-96, 1993.
21 Kuo, T., Kubota, T., Watanabe, M., Furukawa, T., Kase, S., Tanino, H., Nishibori, H., Saikawa, Y., Teramoto, T., Ishibiki, K., Kitajima, M. and Hoffman R.M. Differential chemosensitivity of human small-cell lung carcinoma growing orthotopically and subcutaneously in SCID mice: The importance of orthotopic models to obtain relavant drug evaluation data. Anticancer Research, 13, 627-630, 1993.
22 Kuo, T., Kubota, T., Watanabe, M., Fujita, S., Furukawa, T., Teramoto, T., Ishibiki, K., Kitajima, M. and Hoffman, R.M. Early resection of primary orthotopically-growing human colon tumor in nude mouse prevents liver metastasis: Further evidence for patient-like hematogeneous metastatic route. Anticancer Research, 13, 293-298, 1993.
23 Tanino, H., Kubota, T., Yamada, Y., Koh, J., Takeuchi, T., Kase, S., Furukawa, T., Takahashi, M., Fukuda, S., Ogose, N., Komatsu, N., Kato, M., Kitajima, M., Sakurai, T., Naito, Y. and Hoffman, R.M. A newly developed hexamethylmelamine derivative, SAE9 with both antitumor and aromatase-inhibitory activity. Anticancer Research, 13, 623-626, 1993.
24 Saikawa, Y., Kubota, T., Ogawa, S., Shimada, A., Shibata, S., Furukawa, T., Yamamoto, T., Kumai, K., Yoshino, K., Ishibiki, K., Kitajima, M., Kubota, N. and Kikuchi, T. Usefulness of fecal alpha-1-antitrypsin for detection of gastrointestinal bleeding in patients with gastric cancer. Anticancer Research, 13, 619-622, 1993.
25 Kubota, T., Takahara, T., Nagata, M., Furukawa, T., Kase, S., Tanino, H., Ishibiki, K. and Kitajima, M. Colorimetric chemosensitivity testing using sulforhodamine B. Journal of Surgical Oncology, 52, 83-88, 1993.
26 Kase, S., Kubota, T., Watanabe, M., Takahara, T., Takeuchi, T., Yamaguchi, H., Furukawa, T., Teramoto, T., Kodaira, S., Ishibiki, K. and Kitajima, M. The modulation by l-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo. Surgery Today, 23, 615-620, 1993.
27 Kase, S., Kubota, T., Watanabe, M., Furukawa, T., Tanino, H., Ishibiki, K., Teramoto, T. and Kitajima, M. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Anticancer Research, 13, 369-374, 1993.
28 Saikawa, Y., Kubota, T., Kuo, T., Furukawa, T., Tanino, H., Watanabe, M., Ishibiki, K. and Kitajima, M. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine. Japanese Journal of Cancer Research, 84, 787-793, 1993.
29 Tanino, H., Kubota, T., Saikawa, Y., Kuo, T., Takeuchi, T., Kase, S., Furukawa, T., Kitajima, M., Sakurai, T., Naito, Y. and Hoffman, R.M. Different chemo- and endocrino- sensitivity of MCF-7 cells with or without estradiol supplement in vitro. Anticancer Research, 13, 1219-1222, 1993.
30 Saikawa, Y., Kubota, T., Kuo, T., Kase, S., Furukawa, T., Tanino, H., Ishibiki, K. and Kitajima, M. Synergistic antitumor activity of mitomycin C and cisplatin against gastric cancer cells in vitro. Journal of Surgical Oncology, 54, 98-102, 1993.
31 Kubota, T., Inoue, S., Furukawa, T., Ishibiki, K., Kitajima, M., Kawamura, E. and Hoffman, R.M. Similarity of serum-tumor pharmacokinetics of antitumor agents in man and nude mice. Anticancer Research, 13, 1481-1484, 1993.
32 Furukawa, T., Watanabe, M., Kubota, T. and Kitajima, M. Paradoxical enhancement of tumor growth in mice with severe combined immunodeficiency which produce a human immunoglobulin G reactive against tumor cells. Japanese Journal of Cancer Research, 85, 72-79, 1994.
33 Saikawa, Y., Kubota, T., Kuo, T., Tanino, H., Kase, S., Furukawa, T., Watanabe, M., Ishibiki, K., Kitajima, M. and Hoffman, R.M. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo. Anticancer Research, 14, 461-464, 1994.
34 Saikawa, Y., Kubota, T., Kuo, T., Furukawa, T., Kase, S., Tanino, H., Ishibiki, K., Kitajima, M. and Hoffman, R.M. Antitumor activity of (2”R)-4′-o-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo. Anticancer Research, 14, 469-474, 1994.
35 Saikawa, Y., Kubota, T., Kuo, T., Furukawa, T., Suto, A., Watanabe, M., Kumai, K., Ishibiki, K., Kitajima, M. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. Japanese Journal of Cancer Research, 85, 762-765, 1994.
36 Saikawa, Y., Kubota, T., Kuo, T., Furukawa, T., Kase, S., Tanino, H., Isobe, Y., Watanabe, M., Ishibiki, K., Arimori, M. and Kitajima, M. Synergistic antitumor activity of combination chemotherapy against human gastric cancer xenografts in nude mice. Journal of Surgical Oncology, 56, 242-245, 1994.
37 Saikawa, Y., Kubota, T., Furukawa, T., Kumai, K., Yoshino, K., Ishibiki, K. and Kitajima, M. Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases. Surgery Today, 24, 819-822, 1994.
38 Furukawa, T., Kubota, T. and Hoffman, R.M. Clinical applications of the histoculture drug response assay. Clinical Cancer Research, 1, 305-311, 1995.
39 Kase, S., Kubota, T., Watanabe, M., Furukawa, T., Tanino, H., Kuo, T., Saikawa, Y., Teramoto, T. and Kitajima, M. Recombinant human interferon alpha-2a increases the antitumor activity of 5-fluorouracil (5-FU) on human colon carcinoma xenograft Co-4 without any change in 5-FU pharmacokinetics. Anticancer Research, 15, 153-156, 1995.
40 Tanino, H., Kubota, T., Yamada, Y., Koh, J., Kase, S., Furukawa, T., Kuo, T., Saikawa, Y., Kitajima, M. and Naito, Y. In vivo antitumor activity of hexamethylmelamine against human breast, stomach and colon carcinoma xenografts. Japanese Journal of Cancer Research, 86, 770-775, 1995.
41 Kase, S., Kubota, T., Watanabe, M., Furukawa, T., Tanino, T., Kuo, T., Saikawa, Y., Teramoto, T. and Kitajima, M. Dual modulation by l-leucovorin and recombinant human interferon alpha-2a of 5-furuorouracil antitumor activity against the human colon carcinoma xenograft Co-4. J. Interferon and Cytokine Research, 15, 1089-1093, 1995.
42 Kuo, T., Kubota, T., Watanabe, M., Furukawa, T., Teramoto, T., Ishibiki, K., Kitajima, M., Moossa, A.R., Penman, S. and Hoffman, R.M. Liver colonization competence governs colon cancer metastasis. Proceeding National Academy Science USA, 92, 12085-12089, 1995.
43 Kurihara, N., Kubota, T., Furukawa, T., Watanabe, M., Otani, Y., Kumai, K. and Kitajima, M. Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. Anticancer Research, 19, 5155-5158, 1999.
44 Ohgami, M., Otani, T., Furukawa, T., Kumai, K., Kubota, T., Tokuyama, J., Kim, Y.-I. and Kitajima, M. Laparoscopic surgery for early gastric cancer: lesion-lifting method and intragastric mucosal resection. Hanisch, E., Kitajima, M., Wehrmann, T., Encke, A. (Editors), Endoscopic Gastric Surgery, Springer-Verlag, 97-111, 2000.
45 Ohgami, M., Ishii, S., Arisawa, Y., Ohmori, T., Noga, K., Furukawa, T. and Kitajima, M. Scarless endoscopic thyroidectomy: Breast approach for better cosmesis. Sugical Laparoscopy Endoscopy and Percutaneous Technique, 10, 1-4, 2000.
46 Kitagawa, Y., Kubota, T., Ando, N., Watanabe, M., Ohgami, M., Otani, Y., Ozawa, S., Hasegawa, H., Furukawa, T., Kumai, K., Ikeda, T., Kitajima, M., Fujii, H., Nakahara, T., Kubo, A. and Mukai, M. The role of the sentinel lymph node in gastrointestinal cancer. Surgical Clinics of North America, 80, 1799-1809, 2000.
47 Abe, S., Kubota, T., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K. and Kitajima, M. UCN-01(7-hydroxystaurosporine) enhance 5-fluorouracil cytotoxicity through down-regulation of thymidine synthetase messenger RNA. Japanese Journal Cancer Research, 91, 1192-1198, 2000.
48 Furukawa, T., Morikawa, Y., Ozawa, S., Wakabayashi, G. and Kitajima, M. The revolution of computer-aided surgery the dawn of robotic surgery. Minimally Invasive Therapy and Allied Technology, 10, 283-288, 2001.
49 Furukawa, T., Watanabe, M., Ozawa, S., Otani, Y., Wakabayashi, G., Tanabe, M., Kitagawa, Y., Hasegawa, T., Hoshino, K., Morikawa, Y., Shimazu, M., Ueda, M., Kubota, T. and Kitajima M. Development of endscopic surgery for the minimally invasive treatment of the digestive and other diseases. Keio Journal of Medicine, 50, 167-174, 2001.
50 Abe, S., Kubota, T., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K., Akiyama, T., Akinaga, S. and Kitajima, M. UCN-01 (7-hydroxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery. Japanese Journal of Cancer Research, 92, 537-545, 2001.
51 Kitagawa, Y., Ohgami, M., Fujii, H., Mukai, M., Kubota, T., Ando N., Watanabe, M., Otani, Y., Ozawa, S., Hasegawa, H., Furukawa, T., Matsuda, J., Kumai, K., Ikeda, T., Kubo, A., and Kitajima, M. Laparoscopic detection of sentinel lymph nodes in gastrointestinal cancer: A novel and minimally invasive approach. Annals of Surgical Oncology, 8, 86-89, 2001.
52 Egawa, T., Kubota, T., Furukawa, T., Otani, Y., Watanabe, M., Furukawa, T., Kumai, K. and Kitajima, M. Docetaxel enghances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner. Anticancer Research, 21, 2597-2600, 2001.
53 Minagawa, A, Otani, Y, Kubota, T, Wada, N, F,urukawa, T, Kumai, K, Kameyama, K, Okada, Y, Fujii, M, Yano, M, Sato, T, Ito, A and Kitajima, M. The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Japanese Journal of Cancer Research, 92, 1322-1328, 2001.
54 Egawa, T., Kubota, T., Suto, A., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K. and Kitajima, M. Docetaxel enghances the cytotoxicity of anthracyclines by intracellular drug accumulation. Oncology Report, 9, 777-781, 2002.
55 Kubota, T., Otani Y., Furukawa, T., Hasegawa, H., Watanabe, M. and Kitajima, M. Chemosensitivity testing present and future in Japan. Reinhold, U., Tilgen, W. (Editors), Chemosensitivity testing in oncology, Springer-Verlag (Recent Results in Cancer Research, 161), 231-241, 2003.
56 Otani, Y., Furukawa, T., Suganuma, K., Yoshida, M., Saikawa, Y., Kubota, T., Kumai, K., Mukai, M., Kameyama, K., Takami, H. and Kitajima, M. Minimally invasive surgery for gastric carcinoid tumor. Biomedical Pharmacotherapy, 56, 217s-221s, 2002.
57 Abe, S., Kubota, T., Saikawa, Y., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K. and Kitajima, M. Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers detected by MTT assay. Anticancer Research, 22, 3605-3610, 2002.
58 Kabeshima, Y., Kubota, T., Watanabe, M., Hasegawa, H., Furukawa, T. and Kitajima, M.. Clinical usefulness of chemosensitivity test for advanced colorectal cancer. Anticancer Research, 22, 3033-3038, 2002.
59 Kitagawa, Y., Fujii, H., Mukai, M., Kubota, T., Ando, N., Ozawa, S., Ohtani, Y., Furukawa, T., Yoshida, M., Nakamura, E., Matsuda, J., Shimizu, Y., Nakamura, K., Kumai, K., Kubo, A. and Kitajima, Y. Intraoperative lymphatic mapping and sentinel node sampling in esophageal and gastric cancer. Surgical Oncoogy Clinics of North America, 11, 293-304, 2002.
60 Kubota, T., Otani, Y., Furukawa, T., Hasegawa, H., Watanabe, M. and Kitajima, M. Chemosensitivity Testing – present and future in Japan. Chemosensitivity Testing in Oncology. U Reinhold and W Tilgen (Editors) Springer-Verlag Berlin Heidelberg 2003, pp231-241.
61 Egawa, T., Kubota, T., Suto, A., Otani, Y., Furukawa, T., Saikawa, Y., Watanabe, M., Kumai, K. and Kitajima, M. Antitumor activity of doxorubicin in combination with docetaxel against human breast cancer xenografts. In Vivo, 17,23-28, 2003.
62 Kubota, T., Egawa, T., Suto, A., Otani, Y., Furukawa, T., Saikawa, Y., Yoshida, M., Watanabe, M., Kumai, K. and Kitajima, M. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant chemotherapy for Stage / gastric cancers without peritoneal dissemination. Anticancer Research, 23, 583-588, 2003.
63 Suganuma, K., Kubota, T., Saikawa, Y., Sadanori, A., Otani, Y., Furukawa, T., Kumai, K., Hasegawa, H., Watanabe, M., Kitajima, M, Nakayama, H. and Okabe, H. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray. Cancer Science, 94, 355-359, 2003.
64 Maeda, S., Saikawa, Y., Kubota, T., Aoki, M., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K. and Kitajima, M. No cross-resistance of Taxotere and Taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay. Anticancer Research, 23, 3147-3150, 2003.
65 Wada, N., Otani, Y., Kubota, T., Kimata, M., Minagawa, A., Yoshimizu, N., Kameyama, K., Saikawa, Y., Yoshida, M., Furukawa, T., Fujii, M., Kumai, K., Okada, Y. and Kitajima, M. Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition. Clinical and Experimental Metastasis, 20, 431-435, 2003.
66 Suganuma, K., Otani, Y., Furukawa, T., Saikawa, Y., Yoshida, M., Kubota, T., Kumai, K., Kameyama, K., Mukai, M. and Kitajima, M. Gastric carcinoid tumors with aggressive lymphovascular invasion and lymph node metastasis. Gastric Cancer, 6, 255-261, 2003.
67 Akatsu, Y., Saikawa, Y., Kubota, T., Yoshida, M., Furukawa, T., Otani, Y., Kumai, K. and Kitajima, M. Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low dose cisplatin. Gastric Cancer, 7, 128-133, 2004.
68 Otani, Y., Furukawa, T., Kitagawa, Y., Yoshida, M., Saikawa, Y., Kubota, T., Kumai, K., Matsui, H. and Kitajima, M. New method of laparoscope-assisted function-preserving surgery for early gsstric cancer: vagus-sparing segmrntal gsstrectomy under sentinel node navigation. Journal of the American College of Surgeons, 198, 1026-1031, 2004.
69 Yoshimizu, N., Otani, Y., Saikawa, Y., Kubota, T., Yoshida, M., Furukawa, T., Kumai, K., Kameyama, K., Fujii, M., Yano, M., Sato, T., Ito, A. and Kitajima, M. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproloferative effects, induction of apoptosis and cell cycle deregulation. Alimentary Pharmacological Therapy 20(Suppl.1):95-101, 2004.
70 Tokuyama, J., Kubota, T., Saikawa, Y., Yoshida, M., Furukawa, T., Otani, Y., Kumai, K. and Kitajima, M. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Anticancer Research, 25, 17-22, 2005.
71 Akatsu, T., Yoshida, M., Kubota, T., Shimazu, M., Ueda, M., Otani, Y., Wakabayashi, G., Aiura, K., Tanabe, M., Furukawa, T., Saikawa, Y., Kawachi, S., Akatsu, Y., Kumai, K. and Kitajima, M.. Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World Journal of Surgery, 29, 182-186, 2005.
72 Takahashi, T., Otani, Y., Yoshida, M., Furukawa, T., Kameyama, K., Akiba, Y., Saikawa, Y., Kubota, T., Kumai, K., Kuramochi, S., Mukai, M., Ishii, H. and Kitajima, M. Gastric cancer mimicking a submucosal tumor diagnosed by laparoscopic excision biopsy. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. , 15, 51-56, 2005.
73 Otani, Y., Kitagawa, Y., Furukawa, T., Yoshida, M., Saikawa, Y., Kubota, T., Mukai, M., Kameyama, K., Fujii, H., Kubo, A, Kumai, K. and Kitajima, M. Sentinel node navigation surgery: application to minimally invasive and function-preserving surgery for early gastric cancer. In Diversity of Gastric Carcinoma: Pathogenesis and Therapy, Editors: Michio Kaminishi and Kaiyo Takubo, Springer-Verlag Tokyo, 2005 pp339-34
74 Otani, Y., Furukawa, T., Yoshida, M., Saikawa, Y., Wada, N., Ueda, M., Kubota, T., Mukai, M, kameyama, K., Sugino, Y., Kumai, K. and Kitajima, M. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumors of the stomach based on analysis of 60 operated cases. Surgery, 139, 484-492, 2006.
75 Suganuma, K., Tsukada, K., Kashiba, M., Tsuneshige, A., Furukawa, T., Kubota, T., Goda, N., Kitajima, M., Yonetani, T. and Suematsu, M. Erythrocytes with T-state-stabilized hemoglobin as a therapeutic tool for postischemic liver dysfunction. Antioxidants & Redox Signaling, 8, 1847-1855, 2006.
76 Oguma, J., Ozawa, S., Morikawa, Y., Furukawa, T., Kitagawa, Y., Ueda, M. and Kitajima, M. Knot-tying force during suturing and wound healing in the gastrointestinal tract. J. Surg. Res., 140, 129-134, 2007.